Ipsos Healthcare has joined forces with Arizona State University company HoneyB Health to ‘deliver powerful new insights into connected health’.
The partnership will see HoneyB Health’s proprietary database of physiological assessments of connected health devices linked with Ipsos Healthcare’s global research insights into the attitudes and behaviour of end users and physicians.
The partnership aims to advance how patients, physicians, practitioners and hospitals can use new health technology and devices to share information, inform diagnoses and improve medical treatments.
The first joint project will be the Global Health Survey, which will be conducted by Ipsos Healthcare, and will build upon the academic work conducted by HoneyB Health.
Part of its focus will include patient segmentation related to the drivers and barriers around adoption of connected health devices for type 2 diabetes patients, and an overview of connected health usage among consumer and healthcare professionals in the US, UK and Japan.
Reena Sangar, digital lead at Ipsos Healthcare, told PMLiVE: “Ultimately, the Ipsos Healthcare / HoneyB Health collaboration is driven by a genuine desire to push the connected health agenda forward – and the partnership between an academic and scientific institute and a global research centre of excellence will deliver a unique perspective.”
The research also aims to uncover the role of the healthcare professional in recommending connected health products and services.
Ipsos Healthcare CEO Michael Spedding said: “Connected health has the potential to transform healthcare, and this partnership aims to guide development in the sector so that new technology is optimized for users and healthcare practitioners alike.”
Ipsos Healthcare is the global healthcare division of Ipsos, the world’s third largest market research company. HoneyB Health is a commercial effort to translate the research experience and insights from Project HoneyBee, which administers observational clinical trials that test the utility of commercial wearable devices.